Journal for ImmunoTherapy of Cancer (Nov 2021)
763 Intratumoral delivery of high potency STING agonists modulates the immunosuppressive myeloid compartment and induces curative responses in checkpoint-refractory glioblastoma models
Abstract
No abstracts available.